{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34990293",
  "DateCompleted": {
    "Year": "2022",
    "Month": "05",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "01",
    "Day": "06"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "01",
        "Day": "06"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1200/OP.21.00454"
    ],
    "Journal": {
      "ISSN": "2688-1535",
      "JournalIssue": {
        "Volume": "18",
        "Issue": "5",
        "PubDate": {
          "Year": "2022",
          "Month": "May"
        }
      },
      "Title": "JCO oncology practice",
      "ISOAbbreviation": "JCO Oncol Pract"
    },
    "ArticleTitle": "Exercise Recommendation for People With Bone Metastases: Expert Consensus for Health Care Providers and Exercise Professionals.",
    "Pagination": {
      "StartPage": "e697",
      "EndPage": "e709",
      "MedlinePgn": "e697-e709"
    },
    "Abstract": {
      "AbstractText": [
        "Exercise has been underutilized in people with advanced or incurable cancer despite the potential to improve physical function and reduce psychosocial morbidity, especially for people with bone metastases because of concerns over skeletal complications. The International Bone Metastases Exercise Working Group (IBMEWG) was formed to develop best practice recommendations for exercise programming for people with bone metastases on the basis of published research, clinical experience, and expert opinion.",
        "The IBMEWG undertook sequential steps to inform the recommendations: (1) <i>modified Delphi survey</i>, (2) <i>systematic review</i>, (3) <i>cross-sectional survey</i> to physicians and nurse practitioners, (4) <i>in-person meeting</i> of IBMEWG to review evidence from steps 1-3 to develop draft recommendations, and (5) <i>stakeholder engagement</i>.",
        "Recommendations emerged from the contributing evidence and IBMEWG discussion for pre-exercise screening, exercise testing, exercise prescription, and monitoring of exercise response. Identification of individuals who are potentially at higher risk of exercise-related skeletal complication is a complex interplay of these factors: (1) lesion-related, (2) cancer and cancer treatment-related, and (3) the person-related. Exercise assessment and prescription requires consideration of the location and presentation of bone lesion(s) and should be delivered by qualified exercise professionals with oncology education and exercise prescription experience. Emphasis on postural alignment, controlled movement, and proper technique is essential.",
        "Ultimately, the perceived risk of skeletal complications should be weighed against potential health benefits on the basis of consultation between the person, health care team, and exercise professionals. These recommendations provide an initial framework to improve the integration of exercise programming into clinical care for people with bone metastases."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-2266-1382"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Physical Therapy, University of British Columbia, Vancouver, British Columbia, Canada."
          }
        ],
        "LastName": "Campbell",
        "ForeName": "Kristin L",
        "Initials": "KL"
      },
      {
        "Identifier": [
          "0000-0002-3446-2698"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Australian Catholic University, Melbourne, Australia."
          },
          {
            "Identifier": [],
            "Affiliation": "Peter MacCallum Cancer Centre, East Melbourne, Australia."
          }
        ],
        "LastName": "Cormie",
        "ForeName": "Prue",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Physical Therapy, University of British Columbia, Vancouver, British Columbia, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "BC Cancer, Vancouver, British Columbia, Canada."
          }
        ],
        "LastName": "Weller",
        "ForeName": "Sarah",
        "Initials": "S"
      },
      {
        "Identifier": [
          "0000-0001-7815-6046"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada."
          }
        ],
        "LastName": "Alibhai",
        "ForeName": "Shabbir M H",
        "Initials": "SMH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Karolinska Institute, Stockholm, Sweden."
          }
        ],
        "LastName": "Bolam",
        "ForeName": "Kate A",
        "Initials": "KA"
      },
      {
        "Identifier": [
          "0000-0003-3517-7335"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Edinburgh Napier University, Edinburgh, Scotland."
          }
        ],
        "LastName": "Campbell",
        "ForeName": "Anna",
        "Initials": "A"
      },
      {
        "Identifier": [
          "0000-0001-7668-6115"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Mayo Clinic, Rochester, NY."
          }
        ],
        "LastName": "Cheville",
        "ForeName": "Andrea L",
        "Initials": "AL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Oncology Division of the Canadian Physiotherapy Association, Montreal, Quebec, Canada."
          }
        ],
        "LastName": "Dalzell",
        "ForeName": "Mary-Ann",
        "Initials": "MA"
      },
      {
        "Identifier": [
          "0000-0003-2794-0193"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Edith Cowan University, Joondalup, Australia."
          },
          {
            "Identifier": [],
            "Affiliation": "Queensland University of Technology, Brisbane, Australia."
          }
        ],
        "LastName": "Hart",
        "ForeName": "Nicolas H",
        "Initials": "NH"
      },
      {
        "Identifier": [
          "0000-0001-5308-8972"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Vancouver Prostate Centre, Vancouver, British Columbia, Canada."
          }
        ],
        "LastName": "Higano",
        "ForeName": "Celestia S",
        "Initials": "CS"
      },
      {
        "Identifier": [
          "0000-0002-3786-8191"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Victoria, Victoria, British Columbia, Canada."
          }
        ],
        "LastName": "Lane",
        "ForeName": "Kirstin",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Kansas Cancer Center, Kansas City, MO."
          }
        ],
        "LastName": "Mansfield",
        "ForeName": "Sami",
        "Initials": "S"
      },
      {
        "Identifier": [
          "0000-0003-4376-4847"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Alberta, Edmonton, Alberta, Canada."
          }
        ],
        "LastName": "McNeely",
        "ForeName": "Margaret L",
        "Initials": "ML"
      },
      {
        "Identifier": [
          "0000-0003-0302-6129"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Edith Cowan University, Joondalup, Australia."
          }
        ],
        "LastName": "Newton",
        "ForeName": "Robert U",
        "Initials": "RU"
      },
      {
        "Identifier": [
          "0000-0002-0983-957X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Copenhagen, Copenhagen, Denmark."
          }
        ],
        "LastName": "Quist",
        "ForeName": "Morten",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "BC Cancer, Vancouver, British Columbia, Canada."
          }
        ],
        "LastName": "Rauw",
        "ForeName": "Jennifer",
        "Initials": "J"
      },
      {
        "Identifier": [
          "0000-0002-4147-2958"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "National Center for Tumor Diseases, Heidelberg, Germany."
          }
        ],
        "LastName": "Rosenberger",
        "ForeName": "Friederike",
        "Initials": "F"
      },
      {
        "Identifier": [
          "0000-0003-4361-1656"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Toronto, Toronto, Ontario, Canada."
          }
        ],
        "LastName": "Santa Mina",
        "ForeName": "Daniel",
        "Initials": "D"
      },
      {
        "Identifier": [
          "0000-0003-2400-2935"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Penn State University, Hershey, PA."
          }
        ],
        "LastName": "Schmitz",
        "ForeName": "Kathryn H",
        "Initials": "KH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Oregon Health and Sciences University, Portland, OR."
          }
        ],
        "LastName": "Winters-Stone",
        "ForeName": "Kerri M",
        "Initials": "KM"
      },
      {
        "Identifier": [
          "0000-0002-5971-5436"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "National Center for Tumor Diseases, Heidelberg, Germany."
          }
        ],
        "LastName": "Wiskemann",
        "ForeName": "Joachim",
        "Initials": "J"
      },
      {
        "Identifier": [
          "0000-0003-1533-1489"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "BC Cancer, Victoria, British Columbia, Canada."
          }
        ],
        "LastName": "Goulart",
        "ForeName": "Jennifer",
        "Initials": "J"
      }
    ],
    "GrantList": [
      {
        "GrantID": "P30 CA069533",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 CA218093",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 CA222605",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "JCO Oncol Pract",
    "NlmUniqueID": "101758685",
    "ISSNLinking": "2688-1527"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Consensus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cross-Sectional Studies"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Exercise"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Exercise Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Health Personnel"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neoplasms"
    }
  ],
  "CoiStatement": "<b>Kristin L. Campbell</b><b>Honoraria:</b> Astellas Pharma <b>Prue Cormie</b><b>Stock and Other Ownership Interests:</b> Exercise Oncology EDU Pty Ltd<b>Other Relationship:</b> EX-MED Cancer Ltd <b>Sarah Weller</b><b>Research Funding:</b> Astellas Pharma <b>Shabbir M. H. Alibhai</b><b>Stock and Other Ownership Interests:</b> ResMed<b>Honoraria:</b> Astellas Scientific and Medical Affairs Inc <b>Kate A. Bolam</b><b>Stock and Other Ownership Interests:</b> Novo Nordisk <b>Celestia S. Higano</b><b>Employment:</b> CTI BioPharma Corp (I)<b>Stock and Other Ownership Interests:</b> CTI BioPharma Corp (I)<b>Honoraria:</b> Astellas Pharma<b>Consulting or Advisory Role:</b> Bayer, Ferring, Clovis Oncology, Blue Earth Diagnostics, Janssen, Hinova Pharmaceuticals, Pfizer, AstraZeneca, Carrick Therapeutics, Novartis, Merck Sharp & Dohme, Astellas Pharma, Myovant Sciences, Genentech, Menarini<b>Research Funding:</b> Aragon Pharmaceuticals (Inst), AstraZeneca (Inst), Medivation (Inst), Emergent BioSolutions (Inst), Bayer (Inst), Pfizer (Inst), Roche (Inst), Astellas Pharma (Inst), Clovis Oncology (Inst), Ferring (Inst), eFFECTOR Therapeutics (Inst)<b>Travel, Accommodations, Expenses:</b> Pfizer, Janssen Oncology, Novartis, Merck Sharp & Dohme, Carrick Therapeutics <b>Kirstin Lane</b><b>Stock and Other Ownership Interests:</b> Moderna Therapeutics<b>Travel, Accommodations, Expenses:</b> Astellas Pharma <b>Robert U. Newton</b><b>Honoraria:</b> GenesisCare<b>Research Funding:</b> Ipsen<b>Travel, Accommodations, Expenses:</b> Genesis Cancer Care <b>Morten Quist</b><b>Employment:</b> Zealand Pharmaceuticals (I)<b>Honoraria:</b> AstraZeneca <b>Jennifer Rauw</b><b>Honoraria:</b> AstraZeneca<b>Speakers' Bureau:</b> GlaxoSmithKline<b>Travel, Accommodations, Expenses:</b> AstraZeneca <b>Friederike Rosenberger</b><b>Stock and Other Ownership Interests:</b> BioNTech, Bristol Myers Squibb, AstraZeneca<b>Honoraria:</b> Bristol Myers Squibb, Hexal <b>Kathryn H. Schmitz</b><b>Patents, Royalties, Other Intellectual Property:</b> Fees from the educational program I developed that are now offered through Klose Training and Consulting <b>Joachim Wiskemann</b><b>Honoraria:</b> Pfizer, Lilly, Novartis <b>Jennifer Goulart</b><b>Research Funding:</b> Astellas Pharma (Inst)No other potential conflicts of interest were reported."
}